Quarterly ResultOct 28, 2026, 06:31 AM
GE HealthCare Q3 Revenue $5.5B (+7.2% YoY); Raises 2026 Guidance
AI Summary
GE HealthCare Technologies Inc. announced strong third quarter 2026 financial results, exceeding expectations and leading to a raised full-year guidance. The company reported a 7.2% increase in revenue to $5.5 billion and a 39.1% rise in diluted EPS to $1.36. Key strategic developments include plans to acquire SOFIE Biosciences for $945 million and a 14% increase in the quarterly dividend. However, the company also announced the upcoming departure of Jeannette Bankes, President and CEO of Patient Care Solutions.
Key Highlights
- GE HealthCare reported Q3 2026 revenue of $5.5 billion, up 7.2% YoY, with organic revenue growth of 6.2%.
- Diluted EPS was $1.36, a 39.1% increase YoY, and Adjusted EPS was $1.34, up 25.1% YoY.
- Net income was $615 million, a 37.9% increase YoY, and Adjusted EBIT was $913 million, up 19.9% YoY.
- The company raised its full-year 2026 guidance for organic revenue growth, Adjusted EBIT margin, and Adjusted EPS.
- GE HealthCare plans to acquire SOFIE Biosciences for $945 million, expected to close in H1 2027.
- Quarterly dividend increased by 14% to $0.04 per share.
- Jeannette Bankes will resign as President and CEO of Patient Care Solutions, effective November 15, 2026.
- Cash flow from operating activities was $907 million, up 52.9% YoY; Free cash flow was $793 million, up 64.2% YoY.
Price Impact
More from GEHC